Canada markets close in 3 hours 28 minutes
  • S&P/TSX

    18,226.59
    +100.87 (+0.56%)
     
  • S&P 500

    3,786.97
    +18.50 (+0.49%)
     
  • DOW

    31,125.52
    +201.38 (+0.65%)
     
  • CAD/USD

    0.7899
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    65.95
    +2.12 (+3.32%)
     
  • BTC-CAD

    60,778.56
    -2,676.47 (-4.22%)
     
  • CMC Crypto 200

    959.00
    +15.83 (+1.68%)
     
  • GOLD FUTURES

    1,698.20
    -2.50 (-0.15%)
     
  • RUSSELL 2000

    2,124.05
    -22.87 (-1.07%)
     
  • 10-Yr Bond

    1.5590
    +0.0090 (+0.58%)
     
  • NASDAQ

    12,695.33
    -28.14 (-0.22%)
     
  • VOLATILITY

    28.12
    -0.45 (-1.58%)
     
  • FTSE

    6,630.52
    -20.36 (-0.31%)
     
  • NIKKEI 225

    28,864.32
    -65.79 (-0.23%)
     
  • CAD/EUR

    0.6625
    +0.0033 (+0.50%)
     

Accelerate Diagnostics: 4Q Earnings Snapshot

·1 min read

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Tuesday reported a loss of $18.9 million in its fourth quarter.

On a per-share basis, the Tucson, Arizona-based company said it had a loss of 33 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The maker of systems that diagnose drug-resistant infections posted revenue of $3.1 million in the period.

For the year, the company reported that its loss narrowed to $78.2 million, or $1.40 per share. Revenue was reported as $11.2 million.

Accelerate Diagnostics shares have increased 47% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $11.15, a fall of 28% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXDX at https://www.zacks.com/ap/AXDX